Combination of motherwort injection and oxytocin for the prevention of postpartum hemorrhage after cesarean section

What Was Tested

This randomized controlled trial paper looks at Oxytocin.

Who Took Part

By PubMed's age tags, the people studied were adults, women only.

How the Study Was Run

The design is described as randomized and double-blind.

Random assignment meant chance, not the researchers, decided who got Oxytocin and who got the comparison, which limits bias.

As a double-blind Oxytocin study, the assignments were hidden from both participants and investigators until the end.

From March 2011 and February 2013, a randomized study was conducted on 165 primipara undergoing CS. 83 and 82 cases were placed into the combination of oxytocin and motherwort group and oxytocin group, respectively.

Blood loss was calculated and measured during three periods: from placental delivery to the end of CS, from the end of CS to 2 h postpartum and from 2 h postpartum to 24 h postpartum.

Vital signs were also measured.

What Was Measured

Topics PubMed links to this paper include Cesarean Section, Delivery, Obstetric, Leonurus, Oxytocics, Oxytocin and Postpartum Hemorrhage.

Author keywords: motherwort.

What This Means in Plain Language

The paper is a randomized and double-blind study of Oxytocin.

The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2016 (The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians), a journal based in England.

More context: the Oxytocin compound page, all human trials.